[REGN] QoQ Quarter Result on 30-Sep-2010 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
28-Oct-2010
Financial Year
2010
Quarter
30-Sep-2010 [#Q3]
Profit Trend
QoQ- -32.98%
YoY- -3,237.44%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
Revenue 107,810 112,204 133,675 105,979 115,886 103,534 96,800 7.46%
PBT -63,368 -43,663 -14,597 -31,641 -23,132 -30,304 -40,611 34.63%
Tax -863 -216 846 -906 -1,184 218 -4,122 -64.84%
NP -62,505 -43,447 -14,597 -33,875 -25,474 -30,522 -36,489 43.30%
Tax Rate - - - - - - - -
Total Cost 170,315 155,651 148,272 139,854 141,360 134,056 133,289 17.80%
Ratio Analysis
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
NP Margin -57.98 -38.72 -10.92 -31.96 -21.98 -29.48 -37.70 33.34%
Per Share
30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 CAGR
EPS -0.69 -0.49 -0.17 -0.41 -0.31 -0.38 -0.46 31.13%
EPS Diluted -0.69 -0.49 -0.17 -0.41 -0.31 -0.38 -0.45 33.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.